Primer on renal transplantation.
Renal transplantation transforms chronically ill children with end stage renal disease (ESRD) into near normal resulting in improvement in nutrition, growth, neurodevelopment and quality of life, and is the goal of therapy. However, the benefits of transplantation come at a price of life-long treatment with immunosuppressive medications, increased risk of infections and malignancy. Children younger than 10 y of age have the best, and adolescents have the worst 5-y graft survival likely due to non-adherence with medications in the adolescents. Long-term complications include ongoing issues related to chronic kidney disease (CKD) and cardiovascular morbidity and mortality contributing to graft loss and shortened life expectancy, thus limiting the success of organ transplantation. Therefore, appropriate management of CKD and cardiovascular issues should be integral to the care of pediatric transplant patients. The other ongoing challenges include organ shortage, prevention and treatment of late acute rejections and chronic graft dysfunction, discovering reliable noninvasive immune monitoring tools, improving adherence, psychosocial rehabilitation, and the elusive goal of tolerance.
Department of Nephrology, Children's National Medical Center, 111 Michigan Avenue, NW Washington, DC 20010, USA. amoudgil@childrensnational.org
Asha
A
Moudgil
D000293:Adolescent; D002648:Child; D051799:Delayed Graft Function / Q000175:diagnosis / Q000188:drug therapy; D006084:Graft Rejection / Q000175:diagnosis / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000534:rehabilitation / Q000601:surgery*; D016030:Kidney Transplantation / Q000276:immunology / Q000379:methods / Q000534:rehabilitation; D019520:Living Donors; D011183:Postoperative Complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011300:Preoperative Care; D060305:Transition to Adult Care
D007166:Immunosuppressive Agents